# Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects

> **NCT03041792** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 61 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Liraglutide
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT03041792
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-02-20
- **Primary completion:** 2018-01-16
- **Final completion:** 2018-01-16
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2019-07-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03041792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03041792, "Methodology Study To Examine 6-Week Food Intake With Liraglutide In Obese Subjects". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03041792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*